Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572097
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic HyperplasiaShanghai East HospitalNot Yet RecruitingNot Applicable
NCT07572097Not Yet Recruiting
Not Applicable
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prost...Shanghai East Hospital
NCT07573397
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal CancerFudan UniversityNot Yet Recruiting
NCT07573397Not Yet Recruiting
—
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predictin...Fudan University
NCT07573124
Efficacy of Combining Mulligan Spinal Mobilization With Leg Movement and Mechanical Lumbar Traction in Lumbar RadiculopathyKhyber Medical University PeshawarRecruitingNot Applicable
NCT07573124Recruiting
Not Applicable
Efficacy of Combining Mulligan Spinal Mobilization With Leg Movement and Mechani...Khyber Medical University...
NCT07572838
Alter-Ego as an Assistive Robotic Device.Istituti Clinici Scientifici Maugeri SpANot Yet Recruiting
NCT07572032
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot StudyAjou University Medical CenterNot Yet RecruitingPhase 4
NCT07572032Not Yet Recruiting
Phase 4
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology...Ajou University Medical C...
NCT07571941
Effects of CO Level on Pain, Sensory Function, and Subjective HealthIzmir Democracy UniversityNot Yet Recruiting
NCT07571941Not Yet Recruiting
—
Effects of CO Level on Pain, Sensory Function, and Subjective HealthIzmir Democracy Universit...
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07574242
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 UniversityCompletedNot Applicable
NCT07574242Completed
Not Applicable
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 University
NCT07573332
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07573332Not Yet Recruiting
Phase 1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 An...Bristol-Myers Squibb
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07572669
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRecruitingPhase 2
NCT07572669Recruiting
Phase 2
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogen...Union Hospital, Tongji Me...
NCT07574359
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes in the Russian PopulationPirogov Russian National Research Medical UniversityRecruiting
NCT07574359Recruiting
—
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes...Pirogov Russian National...
NCT07573800
tDCS and the Cardiovascular System in Community-dwelling Elderly.Riphah International UniversityNot Yet RecruitingNot Applicable
NCT07573800Not Yet Recruiting
Not Applicable
tDCS and the Cardiovascular System in Community-dwelling Elderly.Riphah International Univ...
NCT07572266
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Human and Machine CognitionNot Yet RecruitingNot Applicable
NCT07572266Not Yet Recruiting
Not Applicable
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Hum...
NCT07572253
A Study of Using CARTO SOUND™ FAM to Guide Pulsed Field Ablation for Atrial FibrillationCentral China Fuwai Hospital of Zhengzhou UniversityNot Yet RecruitingNot Applicable
NCT07572253Not Yet Recruiting
Not Applicable
A Study of Using CARTO SOUND™ FAM to Guide Pulsed Field Ablation for Atrial Fibr...Central China Fuwai Hospi...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573449
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male ParticipantsOtsuka Pharmaceutical Development & Commercialization, Inc.CompletedPhase 1
NCT07573449Completed
Phase 1
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Si...Otsuka Pharmaceutical Dev...
NCT07572201
The Effect of Kinesio Taping Applied to the Gastrocnemius Muscle on Muscle Oxygenation, Pain Pressure Threshold, and Muscle Mechanical PropertiesOkan UniversityNot Yet RecruitingNot Applicable
NCT07572201Not Yet Recruiting
Not Applicable
The Effect of Kinesio Taping Applied to the Gastrocnemius Muscle on Muscle Oxyge...Okan University
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
Result Breakdown
Not yet recruiting14 (70%)
Recruiting3 (15%)
Completed2 (10%)
Unknown1 (5%)
not_applicable9 (45%)
Not Specified6 (30%)
Phase 13 (15%)
Phase 41 (5%)
Phase 21 (5%)